| Year |
Citation |
Score |
| 2024 |
Desai P, Takahashi N, Kumar R, Nichols S, Malin J, Hunt A, Schultz C, Cao Y, Tillo D, Nousome D, Chauhan L, Sciuto L, Jordan K, Rajapakse V, Tandon M, ... ... Conrads T, et al. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities. Cell Reports. Medicine. 5: 101610. PMID 38897168 DOI: 10.1016/j.xcrm.2024.101610 |
0.662 |
|
| 2024 |
Bateman NW, Abulez T, Tarney CM, Bariani MV, Driscoll JA, Soltis AR, Zhou M, Hood BL, Litzi T, Conrads KA, Jackson A, Oliver J, Ganakammal SR, Schneider F, Dalgard CL, ... ... Conrads TP, et al. Multi-omic Analysis of Uterine Leiomyomas in Self-Described Black and White Women: Molecular Insights into Health Disparities. American Journal of Obstetrics and Gynecology. PMID 38723985 DOI: 10.1016/j.ajog.2024.04.051 |
0.584 |
|
| 2024 |
Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, ... ... Conrads TP, et al. Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities. Npj Precision Oncology. 8: 97. PMID 38710993 DOI: 10.1038/s41698-024-00588-9 |
0.617 |
|
| 2024 |
Kopelman ZA, Tian C, Tumas J, Phippen NT, Tarney CM, Hope ER, Winkler SS, Jokajtys S, Kucera CW, Chan JK, Richardson MT, Kapp DS, Hamilton CA, Leath CA, Jones NL, ... ... Conrads TP, et al. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials. Gynecologic Oncology. 183: 103-114. PMID 38593674 DOI: 10.1016/j.ygyno.2024.03.026 |
0.604 |
|
| 2024 |
Randall J, Hunt AL, Nutcharoen A, Johnston L, Chouraichi S, Wang H, Winer A, Wadlow R, Huynh J, Davis J, Corgiat B, Bateman NW, Deeken JF, Petricoin EF, Conrads TP, et al. Quantitative proteomic analysis of HER2 protein expression in PDAC tumors. Clinical Proteomics. 21: 24. PMID 38509475 DOI: 10.1186/s12014-024-09476-7 |
0.693 |
|
| 2024 |
Bateman NW, Abulez T, Soltis AR, McPherson A, Choi S, Garsed DW, Pandey A, Tian C, Hood BL, Conrads KA, Teng PN, Oliver J, Gist G, Mitchell D, Litzi TJ, ... ... Conrads TP, et al. Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities. Npj Precision Oncology. 8: 68. PMID 38480868 DOI: 10.1038/s41698-024-00519-8 |
0.665 |
|
| 2024 |
Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA, Casablanca Y, Washington C, Chappell NP, Klopp AH, Shriver CD, Tarney CM, Bateman NW, Conrads TP, et al. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer-Accredited Facilities in the United States. Cancers. 16. PMID 38473428 DOI: 10.3390/cancers16051071 |
0.649 |
|
| 2024 |
Teng PN, Schaaf JP, Abulez T, Hood BL, Wilson KN, Litzi TJ, Mitchell D, Conrads KA, Hunt AL, Olowu V, Oliver J, Park FS, Edwards M, Chiang A, Wilkerson MD, ... ... Conrads TP, et al. ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data. Iscience. 27: 109198. PMID 38439970 DOI: 10.1016/j.isci.2024.109198 |
0.651 |
|
| 2024 |
Kucera CW, Chappell NP, Tian C, Richardson MT, Tarney CM, Hamilton CA, Chan JK, Kapp DS, Leath CA, Casablanca Y, Rojas C, Sitler CA, Wenzel L, Klopp A, Jones NL, ... ... Conrads TP, et al. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecologic Oncology. 184: 224-235. PMID 38340648 DOI: 10.1016/j.ygyno.2024.02.005 |
0.656 |
|
| 2024 |
Winkler SS, Tian C, Casablanca Y, Bateman NW, Jokajtys S, Kucera CW, Tarney CM, Chan JK, Richardson MT, Kapp DS, Liao CI, Hamilton CA, Leath CA, Reddy M, Cote ML, ... ... Conrads TP, et al. Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes. Gynecologic Oncology. 184: 31-42. PMID 38277919 DOI: 10.1016/j.ygyno.2024.01.009 |
0.636 |
|
| 2024 |
Hunt AL, Bateman NW, Barakat W, Makohon-Moore SC, Abulez T, Driscoll JA, Schaaf JP, Hood BL, Conrads KA, Zhou M, Calvert V, Pierobon M, Loffredo J, Wilson KN, Litzi TJ, ... ... Conrads TP, et al. Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling. Clinical Proteomics. 21: 4. PMID 38254014 DOI: 10.1186/s12014-024-09451-2 |
0.672 |
|
| 2023 |
Buddenkotte T, Rundo L, Woitek R, Escudero Sanchez L, Beer L, Crispin-Ortuzar M, Etmann C, Mukherjee S, Bura V, McCague C, Sahin H, Pintican R, Zerunian M, Allajbeu I, Singh N, ... ... Conrads TP, et al. Deep learning-based segmentation of multisite disease in ovarian cancer. European Radiology Experimental. 7: 77. PMID 38057616 DOI: 10.1186/s41747-023-00388-z |
0.616 |
|
| 2023 |
McGee JP, Su P, Durbin KR, Hollas MAR, Bateman NW, Maxwell GL, Conrads TP, Fellers RT, Melani RD, Camarillo JM, Kafader JO, Kelleher NL. Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue. Nature Communications. 14: 7946. PMID 38040721 DOI: 10.1038/s41467-023-43898-5 |
0.643 |
|
| 2023 |
Corvigno S, Badal S, Spradlin ML, Keating M, Pereira I, Stur E, Bayraktar E, Foster KI, Bateman NW, Barakat W, Darcy KM, Conrads TP, Maxwell GL, Lorenzi PL, Lutgendorf SK, et al. In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. Npj Precision Oncology. 7: 115. PMID 37923835 DOI: 10.1038/s41698-023-00454-0 |
0.661 |
|
| 2023 |
Hunt AL, Khan I, Wu AML, Makohon-Moore SC, Hood BL, Conrads KA, Abulez T, Ogata J, Mitchell D, Gist G, Oliver J, Wei D, Chung MA, Rahman S, Bateman NW, ... ... Conrads TP, et al. The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study. Clinical & Experimental Metastasis. PMID 37917186 DOI: 10.1007/s10585-023-10233-7 |
0.655 |
|
| 2023 |
McGee JP, Su P, Durbin KR, Hollas MAR, Bateman NW, Maxwell GL, Conrads TP, Fellers RT, Melani RD, Camarillo JM, Kafader JO, Kelleher NL. Automated imaging and identification of proteoforms directly from ovarian cancer tissue. Nature Communications. 14: 6478. PMID 37838706 DOI: 10.1038/s41467-023-42208-3 |
0.665 |
|
| 2023 |
Teng PN, Barakat W, Tran SM, Tran ZM, Bateman NW, Conrads KA, Wilson KN, Oliver J, Gist G, Hood BL, Zhou M, Maxwell GL, Leggio L, Conrads TP, Lee MR. Brain proteomic atlas of alcohol use disorder in adult males. Translational Psychiatry. 13: 318. PMID 37833300 DOI: 10.1038/s41398-023-02605-0 |
0.589 |
|
| 2023 |
Ao W, Kim HI, Tommarello D, Conrads KA, Hood BL, Litzi T, Abulez T, Teng PN, Dalgard CL, Zhang X, Wilkerson MD, Darcy KM, Tarney CM, Phippen NT, Bakkenist CJ, ... ... Conrads TP, et al. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment. Gynecologic Oncology. 177: 60-71. PMID 37639904 DOI: 10.1016/j.ygyno.2023.08.004 |
0.664 |
|
| 2023 |
Hunt AL, Nutcharoen A, Randall J, Papazian A, Deeken J, Maxwell GL, Bateman NW, Petricoin EF, Benyounes A, Conrads TP, Cannon TL. Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer. The Oncologist. PMID 37255276 DOI: 10.1093/oncolo/oyad129 |
0.638 |
|
| 2023 |
Kucera CW, Tian C, Tarney CM, Presti C, Jokajtys S, Winkler SS, Casablanca Y, Bateman NW, Mhawech-Fauceglia P, Wenzel L, Hamilton CA, Chan JK, Jones NL, Rocconi RP, O'Connor TD, ... ... Conrads TP, et al. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. Jama Network Open. 6: e238437. PMID 37067801 DOI: 10.1001/jamanetworkopen.2023.8437 |
0.636 |
|
| 2023 |
Burdett NL, Willis MO, Alsop K, Hunt AL, Pandey A, Hamilton PT, Abulez T, Liu X, Hoang T, Craig S, Fereday S, Hendley J, Garsed DW, Milne K, Kalaria S, ... ... Conrads TP, et al. Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nature Genetics. PMID 36849657 DOI: 10.1038/s41588-023-01320-2 |
0.668 |
|
| 2022 |
Wong KK, Bateman NW, Ng CW, Tsang YTM, Sun CS, Celestino J, Nguyen TV, Malpica A, Hillman RT, Zhang J, Futreal PA, Rojas C, Conrads KA, Hood BL, Dalgard CL, ... ... Conrads TP, et al. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. Journal of Translational Medicine. 20: 606. PMID 36528667 DOI: 10.1186/s12967-022-03820-x |
0.625 |
|
| 2022 |
Garsed DW, Pandey A, Fereday S, Kennedy CJ, Takahashi K, Alsop K, Hamilton PT, Hendley J, Chiew YE, Traficante N, Provan P, Ariyaratne D, Au-Yeung G, Bateman NW, Bowes L, ... ... Conrads TP, et al. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. Nature Genetics. PMID 36456881 DOI: 10.1038/s41588-022-01230-9 |
0.658 |
|
| 2022 |
Soltis AR, Bateman NW, Liu J, Nguyen T, Franks TJ, Zhang X, Dalgard CL, Viollet C, Somiari S, Yan C, Zeman K, Skinner WJ, Lee JSH, Pollard HB, Turner C, ... ... Conrads TP, et al. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. Cell Reports. Medicine. 3: 100819. PMID 36384096 DOI: 10.1016/j.xcrm.2022.100819 |
0.642 |
|
| 2022 |
Handley KF, Sims TT, Bateman NW, Glassman D, Foster KI, Lee S, Yao J, Yao H, Fellman BM, Liu J, Lu Z, Conrads KA, Hood BL, Barakat W, Zhao L, ... ... Conrads TP, et al. Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics. Jama Network Open. 5: e2236626. PMID 36239936 DOI: 10.1001/jamanetworkopen.2022.36626 |
0.682 |
|
| 2022 |
Penick ER, Bateman NW, Rojas C, Magana C, Conrads K, Zhou M, Hood BL, Wang G, Parikh N, Huang Y, Darcy KM, Casablanca Y, Mhawech-Fauceglia P, Conrads TP, Maxwell GL. Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues. Clinical Proteomics. 19: 35. PMID 36195845 DOI: 10.1186/s12014-022-09372-y |
0.674 |
|
| 2022 |
Casablanca Y, Wang G, Lankes HA, Tian C, Bateman NW, Miller CR, Chappell NP, Havrilesky LJ, Wallace AH, Ramirez NC, Miller DS, Oliver J, Mitchell D, Litzi T, Blanton BE, ... ... Conrads TP, et al. Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. Cancers. 14. PMID 36077609 DOI: 10.3390/cancers14174070 |
0.64 |
|
| 2022 |
Mitchell D, Hunt AL, Conrads KA, Hood BL, Makohon-Moore SC, Rojas C, Maxwell GL, Bateman NW, Conrads TP. Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment. Journal of Visualized Experiments : Jove. PMID 35723500 DOI: 10.3791/64171 |
0.617 |
|
| 2022 |
Zhu Q, Wang J, Yu H, Hu Q, Bateman NW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, Sukumar G, Huang RY, Kaur J, Lele SB, Zsiros E, ... ... Conrads TP, et al. Whole-Genome Sequencing Identifies as a Putative Modifier of Cancer Risk in Mutation Carriers. Cancers. 14. PMID 35625955 DOI: 10.3390/cancers14102350 |
0.659 |
|
| 2022 |
Nolin AC, Tian C, Hamilton CA, Casablanca Y, Bateman NW, Chan JK, Cote ML, Shriver CD, Powell MA, Phippen NT, Conrads TP, Maxwell GL, Darcy KM. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecologic Oncology. PMID 35624045 DOI: 10.1016/j.ygyno.2022.05.013 |
0.595 |
|
| 2022 |
Glassman D, Bateman NW, Lee S, Zhao L, Yao J, Tan Y, Ivan C, Rangel KM, Zhang J, Conrads KA, Hood BL, Abulez T, Futreal PA, Fleming ND, Afshar-Kharghan V, ... ... Conrads TP, et al. Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer. Cancers. 14. PMID 35326647 DOI: 10.3390/cancers14061496 |
0.685 |
|
| 2022 |
Bateman NW, Tarney CM, Abulez TS, Hood BL, Conrads KA, Zhou M, Soltis AR, Teng PN, Jackson A, Tian C, Dalgard CL, Wilkerson MD, Kessler MD, Goecker Z, Loffredo J, ... ... Conrads TP, et al. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. Iscience. 25: 103665. PMID 35036865 DOI: 10.1016/j.isci.2021.103665 |
0.612 |
|
| 2021 |
Cobb LP, Siamakpour-Reihani S, Zhang D, Qin X, Owzar K, Zhou C, Conrads TP, Maxwell GL, Darcy KM, Bateman NW, Litzi T, Bae-Jump V, Secord AA. Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecologic Oncology. PMID 34538531 DOI: 10.1016/j.ygyno.2021.08.010 |
0.608 |
|
| 2021 |
Hunt AL, Bateman NW, Barakat W, Makohon-Moore S, Hood BL, Conrads KA, Zhou M, Calvert V, Pierobon M, Loffredo J, Litzi TJ, Oliver J, Mitchell D, Gist G, Rojas C, ... ... Conrads TP, et al. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens. Iscience. 24: 102757. PMID 34278265 DOI: 10.1016/j.isci.2021.102757 |
0.65 |
|
| 2021 |
Bateman NW, Tarney CM, Abulez T, Soltis AR, Zhou M, Conrads K, Litzi T, Oliver J, Hood B, Driggers P, Viollet C, Dalgard C, Wilkerson M, Catherino W, Hamilton CA, ... ... Conrads TP, et al. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. Scientific Reports. 11: 9371. PMID 33931688 DOI: 10.1038/s41598-021-88585-x |
0.647 |
|
| 2021 |
Siedel JH, Ring KL, Hu W, Dood RL, Wang Y, Baggerly K, Darcy KM, Conrads TP, Gallagher S, Tshiaba P, Neff C, Timms KM, Mangala S, Westin SN, Broaddus R, et al. Clinical significance of homologous recombination deficiency score testing in endometrial Cancer. Gynecologic Oncology. PMID 33563487 DOI: 10.1016/j.ygyno.2020.12.010 |
0.324 |
|
| 2020 |
Xuan Y, Bateman NW, Gallien S, Goetze S, Zhou Y, Navarro P, Hu M, Parikh N, Hood BL, Conrads KA, Loosse C, Kitata RB, Piersma SR, Chiasserini D, Zhu H, ... ... Conrads TP, et al. Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies. Nature Communications. 11: 5248. PMID 33067419 DOI: 10.1038/s41467-020-18904-9 |
0.611 |
|
| 2020 |
Lee S, Zhao L, Rojas C, Bateman NW, Yao H, Lara OD, Celestino J, Morgan MB, Nguyen TV, Conrads KA, Rangel KM, Dood RL, Hajek RA, Fawcett GL, Chu RA, ... ... Conrads TP, et al. Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer. Cell Reports. 31: 107502. PMID 32294438 DOI: 10.1016/J.Celrep.2020.03.066 |
0.691 |
|
| 2020 |
Beer L, Sahin H, Bateman NW, Blazic I, Vargas HA, Veeraraghavan H, Kirby J, Fevrier-Sullivan B, Freymann JB, Jaffe CC, Brenton J, Miccó M, Nougaret S, Darcy KM, Maxwell GL, ... Conrads TP, et al. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis. European Radiology. PMID 32253542 DOI: 10.1007/S00330-020-06755-3 |
0.66 |
|
| 2020 |
Hunt AL, Pierobon M, Baldelli E, Oliver J, Mitchell D, Gist G, Bateman NW, Larry Maxwell G, Petricoin EF, Conrads TP. The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow. Clinical Proteomics. 17: 9. PMID 32165870 DOI: 10.1186/S12014-020-09272-Z |
0.664 |
|
| 2020 |
Rojas C, Tian C, Powell MA, Chan JK, Bateman NW, Conrads TP, Rocconi RP, Jones NL, Shriver CD, Hamilton CA, Maxwell GL, Casablanca Y, Darcy KM. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecologic Oncology. PMID 32029291 DOI: 10.1016/J.Ygyno.2020.01.017 |
0.645 |
|
| 2020 |
Soltis AR, Bateman NW, Conrads TP, Dalgard CL, Hu H, Franks TJ, Liu J, Meerzaman D, Petricoin EF, Chen Q, Yan C, Zhang X, Turner CE, Shriver CD, Moskaluk CA, et al. Abstract 5893: Comprehensive proteogenomic analysis and classification of lung adenocarcinoma Cancer Research. 80: 5893-5893. DOI: 10.1158/1538-7445.Am2020-5893 |
0.383 |
|
| 2020 |
Dvergsten E, Serritella A, Kimble D, McIver M, Karovic S, Thomeas-McEwing V, Yang H, Sharma MR, Conrads TP, Pierobon M, Pytel P, Zhao B, Schwartz LH, Petricoin EF, Szmulewitz R, et al. Abstract 5451: Longitudinal proteomic assessment of patient with metastatic apocrine adenocarcinoma reveals evolutionary selection for androgen-receptor-dependence and therapeutic response Cancer Research. 80: 5451-5451. DOI: 10.1158/1538-7445.Am2020-5451 |
0.379 |
|
| 2019 |
Bateman NW, Teng PN, Hope E, Hood BL, Oliver J, Ao W, Zhou M, Wang G, Tommarello D, Wilson K, Litzy T, Conrads KA, Hamilton CA, Darcy KM, Casablanca Y, ... ... Conrads TP, et al. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Medicine. PMID 31808620 DOI: 10.1002/Cam4.2729 |
0.699 |
|
| 2019 |
Tarney CM, Wang G, Bateman NW, Conrads KA, Zhou M, Hood BL, Loffredo J, Tian C, Darcy KM, Hamilton CA, Casablanca Y, Lokshin A, Conrads TP, Maxwell GL. Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. American Journal of Obstetrics and Gynecology. PMID 31279844 DOI: 10.1016/J.Ajog.2019.06.005 |
0.693 |
|
| 2019 |
Brown TA, Byrd K, Vreeland TJ, Clifton GT, Jackson DO, Hale DF, Herbert GS, Myers JW, Greene JM, Berry JS, Martin J, Elkas JC, Conrads TP, Darcy KM, Hamilton CA, et al. Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer Medicine. PMID 31274231 DOI: 10.1002/Cam4.2378 |
0.333 |
|
| 2019 |
Ehmsen S, Pedersen MH, Wang G, Terp MG, Arslanagic A, Hood BL, Conrads TP, Leth-Larsen R, Ditzel HJ. Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome. Cell Reports. 27: 3927-3938.e6. PMID 31242424 DOI: 10.1016/J.Celrep.2019.05.104 |
0.434 |
|
| 2019 |
Liu S, Matsuzaki J, Wei L, Tsuji T, Battaglia S, Hu Q, Cortes E, Wong L, Yan L, Long M, Miliotto A, Bateman NW, Lele SB, Chodon T, Koya RC, ... ... Conrads TP, et al. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. Journal For Immunotherapy of Cancer. 7: 156. PMID 31221207 DOI: 10.1186/S40425-019-0629-6 |
0.677 |
|
| 2019 |
Kessler MD, Bateman NW, Conrads TP, Maxwell GL, Dunning Hotopp JC, O'Connor TD. Ancestral characterization of 1018 cancer cell lines highlights disparities and reveals gene expression and mutational differences. Cancer. PMID 30865299 DOI: 10.1002/Cncr.32020 |
0.689 |
|
| 2019 |
Shuford S, Elder J, Puls L, Weroha J, Hou X, Zanfagnin V, Nick A, Stany MP, Maxwell L, Conrads T, Corless C, Sood AK, Gevaert M, Crosswell HE, DesRochers TM. Abstract TMIM-069: PROSPECTIVE CLINICAL VALIDATION OF EX VIVO, PATIENT-SPECIFIC RESPONSE PREDICTION TO FIRST-LINE CHEMOTHERAPY Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-069 |
0.433 |
|
| 2019 |
Xu C, Tian C, Wang G, Bijelic L, Bateman NW, Conrads TP, Hamilton CA, Casablanca Y, Maxwell GL, Darcy KM. Treatment and survival in elderly women with gynecologic cancer not inferior with Medicare versus private insurance: A National Cancer Database investigation Gynecologic Oncology. 154: 195-196. DOI: 10.1016/J.Ygyno.2019.04.453 |
0.423 |
|
| 2019 |
Rojas C, Tian C, Huang Y, Zhou K, Bateman NW, Conrads TP, Hamilton CA, Maxwell GL, Casablanca Y, Darcy KM. The contributory factors to racial disparity in survival varied in uterine versus ovarian carcinosarcoma: A National Cancer Database investigation Gynecologic Oncology. 154: 112. DOI: 10.1016/J.Ygyno.2019.04.269 |
0.428 |
|
| 2019 |
Penick ER, Rojas C, Bateman NW, Conrads KA, Zhou M, Wang G, Parikh N, Huang Y, Darcy KM, Hamilton CA, Casablanca Y, Mhawech-Fauceglia P, Conrads TP, Maxwell GL. Tumors from ovarian cancer patients receiving neoadjuvant chemotherapy have unique protein profiles that associate with volume of residual disease after interval debulking surgery Gynecologic Oncology. 154: 59-60. DOI: 10.1016/J.Ygyno.2019.04.142 |
0.441 |
|
| 2019 |
Presti CL, Tian C, Oliver KE, Bateman NW, Conrads TP, Hamilton CA, Casablanca Y, Maxwell GL, Darcy KM. Factors to explain racial disparity in survival for women with uterine cancer: Further investigations by histologic subtype Gynecologic Oncology. 154: 23-24. DOI: 10.1016/J.Ygyno.2019.04.058 |
0.388 |
|
| 2018 |
Dubil EA, Tian C, Wang G, Tarney CM, Bateman NW, Levine DA, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Racial disparities in molecular subtypes of endometrial cancer. Gynecologic Oncology. 149: 106-116. PMID 29605044 DOI: 10.1016/J.Ygyno.2017.12.009 |
0.703 |
|
| 2018 |
Bateman NW, Conrads TP. Recent Advances and Opportunities in Proteomic Analyses of Tumor Heterogeneity. The Journal of Pathology. PMID 29344964 DOI: 10.1002/Path.5036 |
0.661 |
|
| 2018 |
Huang Y, Tarney C, Tian C, Bateman N, Conrads T, Hamilton C, Maxwell G, Darcy K. Abstract A51: Disparities in cervical cancer patients by race and histology Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-A51 |
0.698 |
|
| 2018 |
Penick ER, Mhawech-Fauceglia P, Conrads KA, Bateman NW, Wang G, Parikh N, Hood BL, Hamilton CA, Maxwell GL, Conrads TP. Proteomic profiling of chemotherapy naïve versus neoadjuvant treated ovarian tumors Gynecologic Oncology. 149: 175. DOI: 10.1016/J.Ygyno.2018.04.398 |
0.377 |
|
| 2017 |
Tarney CM, Tian C, Craig ER, Crothers BA, Chan JK, Gist GD, Bateman NW, Conrads TP, Hamilton CA, Larry Maxwell G, Darcy KM. Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 29232272 DOI: 10.1097/Igc.0000000000001156 |
0.63 |
|
| 2017 |
Lemchak D, Banerjee S, Digambar SS, Hood BL, Conrads TP, Jedrych J, Geskin L, Akilov OE. Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and sezary syndrome. Experimental Dermatology. PMID 29205518 DOI: 10.1111/Exd.13477 |
0.318 |
|
| 2017 |
Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecologic Oncology. PMID 28800945 DOI: 10.1016/J.Ygyno.2017.07.145 |
0.674 |
|
| 2017 |
Bateman NW, Dubil EA, Wang G, Hood BL, Oliver JM, Litzi TA, Gist GD, Mitchell DA, Blanton B, Phippen NT, Tian C, Zahn CM, Cohn DE, Havrilesky LJ, Berchuck A, ... ... Conrads TP, et al. Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. PMID 28654152 DOI: 10.1002/Cncr.30813 |
0.685 |
|
| 2017 |
Pedersen MH, Hood BL, Beck HC, Conrads TP, Ditzel HJ, Leth-Larsen R. Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors. Oncoimmunology. 6: e1305531. PMID 28638726 DOI: 10.1080/2162402X.2017.1305531 |
0.456 |
|
| 2017 |
Budiu RA, Vlad AM, Nazario L, Bathula C, Cooper KL, Edmed J, Thaker PH, Urban J, Kalinski P, Lee AV, Elishaev EL, Conrads TP, Flint MS. Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model. Cancer and Clinical Oncology. 6: 12-24. PMID 28603578 DOI: 10.5539/Cco.V6N1P12 |
0.307 |
|
| 2017 |
Russo P, Hood BL, Bateman NW, Conrads TP. Quantitative Mass Spectrometry by Isotope Dilution and Multiple Reaction Monitoring (MRM). Methods in Molecular Biology (Clifton, N.J.). 1606: 313-332. PMID 28502009 DOI: 10.1007/978-1-4939-6990-6_20 |
0.589 |
|
| 2017 |
Teng PN, Bateman NW, Wang G, Litzi T, Blanton BE, Hood BL, Conrads KA, Ao W, Oliver KE, Darcy KM, McGuire WP, Paz K, Sidransky D, Hamilton CA, Maxwell GL, ... Conrads TP, et al. Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Human Cell. PMID 28251557 DOI: 10.1007/s13577-017-0162-1 |
0.641 |
|
| 2017 |
Shoji Y, Kato-Shoji K, Conrads KA, Challa R, Hood BL, Bateman NW, Conrads TP, Risinger JI. Abstract 214: ARID1A and ARID1B dependent proteomics Cancer Research. 77: 214-214. DOI: 10.1158/1538-7445.Am2017-214 |
0.702 |
|
| 2017 |
Penick ER, Tian C, Wang G, Bateman NW, Mhawech-Fauceglia P, Gist G, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Surrogates of progression-free survival in endometrial cancer patients: An evaluation of necrosis and other measures of tissue composition Gynecologic Oncology. 145: 124-125. DOI: 10.1016/J.Ygyno.2017.03.290 |
0.405 |
|
| 2017 |
Bateman NW, Dubil EA, Wang G, Hood BL, Litzi T, Darcy KM, Hamilton CA, Conrads TP, Maxwell GL. Proteogenomic alterations in black endometrioid endometrial cancer patients correlate with poor disease outcome Gynecologic Oncology. 145: 106. DOI: 10.1016/J.Ygyno.2017.03.250 |
0.401 |
|
| 2017 |
Huang Y, Dubil EA, Tian C, Chan JK, Krivak TC, Bateman NW, Conrads TP, Hamilton CA, Darcy KM, Maxwell GL. Racial and ethnic outcome differences in the top five women’s cancers: A harmonized Surveillance, Epidemiology, and End Results study for diagnoses from 2000-2014 Gynecologic Oncology. 145: 93-94. DOI: 10.1016/J.Ygyno.2017.03.219 |
0.374 |
|
| 2017 |
Hope ER, Miller CR, Tian C, Conrads TP, Risinger JI, Hamilton CA, Maxwell GL, Darcy KM. Mutations and transcript expression of maternal embryonic leucine zipper kinase in endometrial cancer patients Gynecologic Oncology. 145: 87-88. DOI: 10.1016/J.Ygyno.2017.03.205 |
0.38 |
|
| 2017 |
Penick ER, Tian C, Bateman NW, Oliver J, Mitchell D, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. CTNNB1 predicts better progression-free survival in endometrioid endometrial cancer patients treated with chemotherapy Gynecologic Oncology. 145: 81. DOI: 10.1016/J.Ygyno.2017.03.191 |
0.406 |
|
| 2017 |
Hope ER, Tarney CM, Bateman NW, Hood BL, Hamilton CA, Maxwell GL, Conrads TP, Makowski L, Bae-Jump VL. Differential proteomic analysis of metformin response in a preoperative-window clinical trial for endometrial cancer Gynecologic Oncology. 145: 32. DOI: 10.1016/J.Ygyno.2017.03.085 |
0.382 |
|
| 2017 |
Sullivan SA, Tran AM, Clark LH, Bateman NW, Hood BL, Conrads TP, Lee D, Zhou C, Makowski L, Bae-Jump VL. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin Gynecologic Oncology. 145: 21. DOI: 10.1016/J.Ygyno.2017.03.064 |
0.332 |
|
| 2017 |
Maxwell GL, Wang G, Tian C, Bateman NW, Casablanca Y, Havrilesky LJ, Birrer MJ, Hamilton CA, Conrads TP, Darcy KM. MS7 a transcript-based diagnostic classifier for metastatic disease and worse progression-free survival in endometrioid endometrial cancer patients Gynecologic Oncology. 145: 12. DOI: 10.1016/J.Ygyno.2017.03.045 |
0.414 |
|
| 2017 |
Dubil EA, Tian C, Wang G, Bateman NW, Levine DA, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. Racial differences in molecular subtypes between black and white patients with endometrial cancer Gynecologic Oncology. 145: 11-12. DOI: 10.1016/J.Ygyno.2017.03.044 |
0.402 |
|
| 2016 |
Jackson DO, Byrd K, Vreeland TJ, Hale DF, Herbert GS, Greene JM, Schneble EJ, Berry JS, Trappey AF, Clifton GT, Hardin MO, Martin J, Elkas JC, Conrads TP, Darcy KM, et al. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. Oncotarget. PMID 27852036 DOI: 10.1016/J.Ygyno.2017.03.068 |
0.376 |
|
| 2016 |
Phippen NT, Bateman NW, Wang G, Conrads KA, Ao W, Teng PN, Litzi TA, Oliver J, Maxwell GL, Hamilton CA, Darcy KM, Conrads TP. NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer. Frontiers in Oncology. 6: 213. PMID 27833898 DOI: 10.3389/fonc.2016.00213 |
0.697 |
|
| 2016 |
Conrads TP, Petricoin EF. The Obama Administration's Cancer Moonshot: A Call for Proteomics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27199492 DOI: 10.1158/1078-0432.CCR-16-0688 |
0.323 |
|
| 2016 |
Bateman NW, Byrd KA, Conrads KA, Risinger JI, Morrison C, Odunsi K, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Abstract A19: Cytoplasmic ARID1A and poor outcome in ovarian cancer patients. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A19 |
0.729 |
|
| 2016 |
Fedorko A, Chandramouli GVR, Kim HI, Shoji Y, Challa R, Darcy KM, Wang G, Schink J, Conrads TP, Risinger J. Abstract LB-111: Elevated CXXC5 is associated with recurrence, poor overall survival and cell viability in endometrial cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-111 |
0.486 |
|
| 2016 |
Miller CR, Maikarfi S, Mitchell D, Zahn CM, Cohn DE, Morrison C, Hamilton CA, Conrads TP, Darcy KM, Maxwell GL. Clinical assessments of MELK immunohistochemical expression in uterine cancer patients: A Gynecologic Cancer Center of Excellence study Gynecologic Oncology. 141: 153. DOI: 10.1016/J.Ygyno.2016.04.400 |
0.449 |
|
| 2015 |
Hope ER, Mhawech-Fauceglia P, Pejovic T, Zahn CM, Wang G, Conrads TP, Larry Maxwell G, Hamilton CA, Darcy KM, Syed V. Nestin: A biomarker of aggressive uterine cancers. Gynecologic Oncology. PMID 26718725 DOI: 10.1016/J.Ygyno.2015.12.015 |
0.422 |
|
| 2015 |
Bateman NW, Shoji Y, Conrads KA, Stroop KD, Hamilton CA, Darcy KM, Maxwell GL, Risinger JI, Conrads TP. Identification and functional characterization of a novel bipartite nuclear localization sequence in ARID1A. Biochemical and Biophysical Research Communications. PMID 26614907 DOI: 10.1016/J.Bbrc.2015.11.080 |
0.629 |
|
| 2015 |
Vendetti FP, Lau A, Schamus S, Conrads TP, O'Connor MJ, Bakkenist CJ. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo. Oncotarget. PMID 26517239 DOI: 10.18632/Oncotarget.6247 |
0.331 |
|
| 2015 |
Gau DM, Lesnock JL, Hood BL, Bhargava R, Sun M, Darcy K, Luthra S, Chandran U, Conrads TP, Edwards RP, Kelley JL, Krivak TC, Roy P. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study. Cell Cycle (Georgetown, Tex.). 14: 1884-92. PMID 25927284 DOI: 10.1080/15384101.2015.1036203 |
0.468 |
|
| 2015 |
Bateman NW, Jaworski E, Ao W, Wang G, Litzi T, Dubil E, Marcus C, Conrads KA, Teng PN, Hood BL, Phippen NT, Vasicek LA, McGuire WP, Paz K, Sidransky D, ... ... Conrads TP, et al. Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients. Journal of Proteome Research. 14: 1900-10. PMID 25748058 DOI: 10.1021/Pr5012894 |
0.701 |
|
| 2015 |
Hood BL, Liu B, Alkhas A, Shoji Y, Challa R, Wang G, Ferguson S, Oliver J, Mitchell D, Bateman NW, Zahn CM, Hamilton CA, Payson M, Lessey B, Fazleabas AT, ... ... Conrads TP, et al. Proteomics of the human endometrial glandular epithelium and stroma from the proliferative and secretory phases of the menstrual cycle. Biology of Reproduction. 92: 106. PMID 25695723 DOI: 10.1095/Biolreprod.114.127217 |
0.645 |
|
| 2015 |
Teng PN, Bateman NW, Darcy KM, Hamilton CA, Maxwell GL, Bakkenist CJ, Conrads TP. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecologic Oncology. 136: 554-61. PMID 25560806 DOI: 10.1016/J.Ygyno.2014.12.035 |
0.678 |
|
| 2015 |
Maxwell GL, Shoji Y, Darcy K, Litzi T, Berchuck A, Hamilton CA, Conrads TP, Risinger JI. MicroRNAs in endometrial cancers from black and white patients. American Journal of Obstetrics and Gynecology. 212: 191.e1-10. PMID 25174797 DOI: 10.1016/J.Ajog.2014.08.028 |
0.383 |
|
| 2015 |
Phippen NT, Bateman NW, Wang G, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Abstract 4632: Poor survival associated with NUAK1 overexpression in serous ovarian cancer may be explained by chemotherapy resistance Cancer Research. 75: 4632-4632. DOI: 10.1158/1538-7445.Am2015-4632 |
0.722 |
|
| 2015 |
Jacobsen K, Hood BL, Olsen KE, Conrads TP, Ditzel H. Abstract C11: Protein biomarkers predictive of outcome in EGFR inhibitor-treated non-small cell lung cancer patients with EGFR wildtype Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C11 |
0.373 |
|
| 2015 |
Pedersen MH, Hood BL, Conrads TP, Ditzel H, Leth-Larsen R. Abstract C10: Quantitative proteomics of formalin-fixed paraffin-embedded, primary triple-negative breast cancer tissues of patients who experienced distant metastasis or no recurrence Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C10 |
0.471 |
|
| 2015 |
Hunn J, Turbov J, Rosales R, Syed V, Conrads TP, Darcy KM, Maxwell GL, Hamilton CA, Thaete LG, Rodriguez GC. Progestins and vitamin D inhibit CYP24A1 in vivo in ovarian cancer cell xenografts Gynecologic Oncology. 137: 204. DOI: 10.1016/J.Ygyno.2015.01.512 |
0.361 |
|
| 2015 |
Phippen NT, Wang G, Bateman NW, Lowery WJ, Stany MP, Hamilton CA, Maxwell GL, Conrads TP, Darcy KM. FIGO staging criteria is a meaningful clinical threshold for evaluating molecular signatures in serous ovarian cancer patients Gynecologic Oncology. 137: 188. DOI: 10.1016/J.Ygyno.2015.01.472 |
0.413 |
|
| 2015 |
Dubil EA, Teng PN, Wang G, Conrads KA, Hood BL, Maxwell GL, Hamilton CA, Conrads TP. Proteomic analysis of cisplatin resistance in the ovarian cancer line CaOv3 Gynecologic Oncology. 137: 135-136. DOI: 10.1016/J.Ygyno.2015.01.337 |
0.405 |
|
| 2015 |
Rodriguez GC, Turbov J, Rosales R, Syed V, Conrads TP, Darcy KM, Maxwell GL, Hamilton CA, Thaete LG. Progestins inhibit calcitriol-induced CYP24A1 in endometrial and ovarian cancer cells Gynecologic Oncology. 137: 64-65. DOI: 10.1016/J.Ygyno.2015.01.151 |
0.422 |
|
| 2014 |
Zaidi AH, Gopalakrishnan V, Kasi PM, Zeng X, Malhotra U, Balasubramanian J, Visweswaran S, Sun M, Flint MS, Davison JM, Hood BL, Conrads TP, Bergman JJ, Bigbee WL, Jobe BA. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma. Cancer. 120: 3902-13. PMID 25100294 DOI: 10.1002/Cncr.28963 |
0.323 |
|
| 2014 |
Vaezi AE, Bepler G, Bhagwat NR, Malysa A, Rubatt JM, Chen W, Hood BL, Conrads TP, Wang L, Kemp CE, Niedernhofer LJ. Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas. Cancer. 120: 1898-907. PMID 24692084 DOI: 10.1002/Cncr.28643 |
0.313 |
|
| 2014 |
Teng PN, Wang G, Hood BL, Conrads KA, Hamilton CA, Maxwell GL, Darcy KM, Conrads TP. Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. British Journal of Cancer. 110: 123-32. PMID 24178762 DOI: 10.1038/bjc.2013.687 |
0.377 |
|
| 2014 |
Challa R, Shoji Y, Conrads KA, Hood BL, Wang G, Darcy KM, Hamilton CA, Maxwell GL, Conrads TP, Risinger JI. Abstract 990: Metastasis suppressor CD82/KAI1 expression is dependent on functional SWI/SNF ARID1A/B Cancer Research. 74: 990-990. DOI: 10.1158/1538-7445.Am2014-990 |
0.331 |
|
| 2014 |
Shoji Y, Conrads KA, Challa R, Hood BL, Wang G, Darcy KM, Hamilton CA, Maxwell GL, Conrads TP, Risinger JI. Abstract 1570: ARID1A regulation of ATAD2 in gynecologic cancer Cancer Research. 74: 1570-1570. DOI: 10.1158/1538-7445.Am2014-1570 |
0.49 |
|
| 2014 |
Byrd KA, Bateman NW, Wang G, Hood BL, Darcy KM, Zahn C, Hamilton CA, Lancaster JM, Maxwell GL, Conrads TP. Correlation of survival-stratified proteomic and curated gene data reveal a three-protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer Gynecologic Oncology. 133: 205-206. DOI: 10.1016/J.Ygyno.2014.03.546 |
0.414 |
|
| 2014 |
Chappell NP, Mieznikowski J, Wang G, Hood BL, McMeekin DS, Hamilton CA, Conrads TP, Maxwell GL, Wallace A, Ramirez N, Shepherd L, Rose GS. Proteomic profiling of stage I endometrial cancers: A signature of early-stage recurrence in GOG 8016 Gynecologic Oncology. 133: 136. DOI: 10.1016/J.Ygyno.2014.03.354 |
0.364 |
|
| 2014 |
Marcus CS, Hood BL, Wang G, Bateman NW, Conrads KA, Dubil EA, Darcy KM, Maxwell GL, Hamilton CA, Conrads TP. Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells Gynecologic Oncology. 133: 124. DOI: 10.1016/J.Ygyno.2014.03.326 |
0.393 |
|
| 2014 |
Phippen NT, Wang G, Bateman NW, Litzi T, Lowery WJ, Berchuck A, Maxwell GL, Hamilton CA, Conrads TP, Darcy KM. Curated Ovarian Database-derived identification of genes predicting survival in primary serous epithelial ovarian cancer Gynecologic Oncology. 133: 120. DOI: 10.1016/J.Ygyno.2014.03.315 |
0.414 |
|
| 2014 |
Teng P, Bateman N, Conrads K, Oliver K, Hamilton C, Maxwell G, Bakkenist C, Conrads T. Enhanced gynecologic cancer cell killing through pharmacologic inhibition of the ataxia telangiectasia and Rad3-related kinase Gynecologic Oncology. 133: 108-109. DOI: 10.1016/J.Ygyno.2014.03.289 |
0.38 |
|
| 2014 |
Byrd K, Maxwell G, Bshara W, Risinger J, Tian C, Omilian A, Odunsi K, Morrison C, Conrads T, Consortium W. Subcellular localization of AT-rich interactive domain1A protein expression is associated with survival in epithelial ovarian and peritoneal carcinoma Gynecologic Oncology. 133: 93-94. DOI: 10.1016/J.Ygyno.2014.03.249 |
0.323 |
|
| 2014 |
Byrd KA, Schneble E, Ponniah S, McGuire WP, Conrads TP, Elkas JC, Darcy KM, Maxwell GL, Hamilton CA, Peoples G. Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence Gynecologic Oncology. 133: 40-41. DOI: 10.1016/J.Ygyno.2014.03.118 |
0.374 |
|
| 2014 |
Bateman N, Teng P, Conrads K, Hamilton C, Maxwell G, Bakkenist C, Conrads T. Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation Gynecologic Oncology. 133: 21. DOI: 10.1016/J.Ygyno.2014.03.072 |
0.328 |
|
| 2014 |
Risinger JI, Shoji Y, Conrads KA, Challa R, Hood BL, Wang G, Darcy KM, Hamilton CA, Maxwell GL, Conrads TP. Pathogenesis of ARID1A -driven gynecologic cancer Gynecologic Oncology. 133: 19-20. DOI: 10.1016/J.Ygyno.2014.03.069 |
0.44 |
|
| 2014 |
Casablanca Y, Mieznikowski J, Day R, Hamilton CA, Conrads TP, Maxwell GL, Hood BL, Wallace A, Rose GS, McMeekin DS. Molecular profiling of tumors from stage I versus stage III/IV cancer patients: A prediction signature for metastasis in Gynecologic Oncology Group 8024 Gynecologic Oncology. 133: 6. DOI: 10.1016/J.Ygyno.2014.03.031 |
0.478 |
|
| 2013 |
Risinger JI, Allard J, Chandran U, Day R, Chandramouli GV, Miller C, Zahn C, Oliver J, Litzi T, Marcus C, Dubil E, Byrd K, Cassablanca Y, Becich M, Berchuck A, ... ... Conrads TP, et al. Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Frontiers in Oncology. 3: 139. PMID 23785665 DOI: 10.3389/Fonc.2013.00139 |
0.367 |
|
| 2013 |
Semmes OJ, Conrads T. Focus on cancer proteomics. Proteomics. Clinical Applications. 7: 315. PMID 23780814 DOI: 10.1002/prca.201370034 |
0.343 |
|
| 2013 |
Lee LR, Teng PN, Nguyen H, Hood BL, Kavandi L, Wang G, Turbov JM, Thaete LG, Hamilton CA, Maxwell GL, Rodriguez GC, Conrads TP, Syed V. Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 6: 731-43. PMID 23682076 DOI: 10.1158/1940-6207.Capr-12-0493 |
0.403 |
|
| 2013 |
Maxwell GL, Allard J, Gadisetti CV, Litzi T, Casablanca Y, Chandran U, Darcy KM, Levine DA, Berchuck A, Hamilton CA, Conrads TP, Risinger JI. Transcript expression in endometrial cancers from Black and White patients. Gynecologic Oncology. 130: 169-73. PMID 23603370 DOI: 10.1016/J.Ygyno.2013.04.017 |
0.453 |
|
| 2013 |
Camalier CE, Yi M, Yu LR, Hood BL, Conrads KA, Lee YJ, Lin Y, Garneys LM, Bouloux GF, Young MR, Veenstra TD, Stephens RM, Colburn NH, Conrads TP, Beck GR. An integrated understanding of the physiological response to elevated extracellular phosphate. Journal of Cellular Physiology. 228: 1536-50. PMID 23280476 DOI: 10.1002/Jcp.24312 |
0.301 |
|
| 2013 |
Rao UN, Hood BL, Jones-Laughner JM, Sun M, Conrads TP. Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study. Human Pathology. 44: 725-33. PMID 23063503 DOI: 10.1016/J.Humpath.2012.06.023 |
0.331 |
|
| 2013 |
Maxwell GL, Chandramouli G, Litzi T, Berchuck A, Conrads TP, Risinger JI. Abstract 1966: Analysis of micro RNAs in the racial disparity of endometrial cancer . Cancer Research. 73: 1966-1966. DOI: 10.1158/1538-7445.Am2013-1966 |
0.424 |
|
| 2013 |
Lee LR, Hood BL, Nguyen H, Kavandi L, Turbov JM, Thaete LG, Hamilton CA, Rodriguez GC, Maxwell GL, Conrads TP, Syed V. Abstract 1716: Calcitriol and progesterone synergistically inhibit growth in endometrial cancer cells. Cancer Research. 73: 1716-1716. DOI: 10.1158/1538-7445.Am2013-1716 |
0.419 |
|
| 2012 |
Barbi de Moura M, Vincent G, Fayewicz SL, Bateman NW, Hood BL, Sun M, Suhan J, Duensing S, Yin Y, Sander C, Kirkwood JM, Becker D, Conrads TP, Van Houten B, Moschos SJ. Mitochondrial respiration--an important therapeutic target in melanoma. Plos One. 7: e40690. PMID 22912665 DOI: 10.1371/Journal.Pone.0040690 |
0.656 |
|
| 2012 |
Allard JE, Chandramouli GV, Stagliano K, Hood BL, Litzi T, Shoji Y, Boyd J, Berchuck A, Conrads TP, Maxwell GL, Risinger JI. Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer. Frontiers in Oncology. 2: 65. PMID 22783543 DOI: 10.3389/Fonc.2012.00065 |
0.415 |
|
| 2012 |
Zhao T, Zeng X, Bateman NW, Sun M, Teng PN, Bigbee WL, Dhir R, Nelson JB, Conrads TP, Hood BL. Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard. Journal of Proteome Research. 11: 1089-99. PMID 22077639 DOI: 10.1021/Pr200829F |
0.621 |
|
| 2012 |
Chappell NP, Teng P, Hood BL, Hamilton CA, Maxwell GL, Conrads TP. Abstract 842: Proteomics-based comparative analysis of mitochondria isolated from human cisplatin-sensitive and resistant ovarian carcinoma cell lines Cancer Research. 72: 842-842. DOI: 10.1158/1538-7445.Am2012-842 |
0.431 |
|
| 2012 |
Teng P, Hood BL, Litzi T, Chappell NP, Hamilton CA, Maxwell GL, Conrads TP. Abstract 799: Comprehensive proteomic analysis of cisplatin resistance in ovarian cancer Cancer Research. 72: 799-799. DOI: 10.1158/1538-7445.Am2012-799 |
0.38 |
|
| 2011 |
Rungruang B, Teng P, Hood BL, Sun M, Flint MS, Bateman NW, Jones-Laughner J, Maxwell GL, Krivak TC, Conrads TP. Mre11 as a biomarker of platinum resistance in epithelial ovarian cancer cell lines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15527. PMID 28023925 DOI: 10.1200/Jco.2011.29.15_Suppl.E15527 |
0.439 |
|
| 2011 |
Oliver KE, Enewold L, Zhu K, Conrads TP, Rose GS, Maxwell GL, Farley JH. The presence of racial disparities in histopathologic characteristics of uterine cancer in an equal-access environment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5094. PMID 28023632 DOI: 10.1200/Jco.2011.29.15_Suppl.5094 |
0.432 |
|
| 2011 |
Hoskins ER, Hood BL, Sun M, Krivak TC, Edwards RP, Conrads TP. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. Plos One. 6: e25056. PMID 21980378 DOI: 10.1371/Journal.Pone.0025056 |
0.432 |
|
| 2011 |
Oliver KE, Enewold LR, Zhu K, Conrads TP, Rose GS, Maxwell GL, Farley JH. Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment. Gynecologic Oncology. 123: 76-81. PMID 21741078 DOI: 10.1016/J.Ygyno.2011.06.027 |
0.385 |
|
| 2011 |
Maxwell GL, Hood BL, Day R, Chandran U, Kirchner D, Kolli VS, Bateman NW, Allard J, Miller C, Sun M, Flint MS, Zahn C, Oliver J, Banerjee S, Litzi T, ... ... Conrads TP, et al. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation. Gynecologic Oncology. 121: 586-94. PMID 21458040 DOI: 10.1016/J.Ygyno.2011.02.031 |
0.7 |
|
| 2011 |
Zeng X, Hood BL, Zhao T, Conrads TP, Sun M, Gopalakrishnan V, Grover H, Day RS, Weissfeld JL, Wilson DO, Siegfried JM, Bigbee WL. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 725-34. PMID 21304412 DOI: 10.1097/Jto.0B013E31820C312E |
0.396 |
|
| 2011 |
Bateman NW, Sun M, Bhargava R, Hood BL, Darfler MM, Kovatich AJ, Hooke JA, Krizman DB, Conrads TP. Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. Journal of Proteome Research. 10: 1323-32. PMID 21155598 DOI: 10.1021/pr101073s |
0.69 |
|
| 2011 |
Lu X, Beck GR, Gilbert LC, Camalier CE, Bateman NW, Hood BL, Conrads TP, Kern MJ, You S, Chen H, Nanes MS. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 209-19. PMID 20683885 DOI: 10.1002/Jbmr.203 |
0.626 |
|
| 2011 |
Zorn KK, Rungruang B, Hood BL, Mai S, Chivukula M, Nikiforova M, Conrads TP. Abstract 4876: Proteomic analysis of pelvic tissues at the time of risk-reducing surgery in BRCA mutation carriers Cancer Research. 71: 4876-4876. DOI: 10.1158/1538-7445.Am2011-4876 |
0.392 |
|
| 2011 |
Flint MS, Budiu RA, Conrads TP, Vlad AM. Abstract 1835: Mechanisms of psychological stress on the adaptive immune system and disease progression in a novel double transgenic ovarian cancer mouse model Cancer Research. 71: 1835-1835. DOI: 10.1158/1538-7445.Am2011-1835 |
0.37 |
|
| 2011 |
Lesnock J, Hood B, Sun M, Teng B, Rungruang B, Flint M, Krivak T, Conrads T. Proteomic analysis demonstrates that BRCA1-deficient epithelial ovarian cancer cell lines activate alternative pathways following exposure to cisplatin Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.130 |
0.417 |
|
| 2011 |
Hoskins E, Hood B, Sun M, Krivak T, Conrads T, Edwards R. Epithelial ovarian cancer tumor microenvironment is a favorable biomarker resource Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.118 |
0.448 |
|
| 2011 |
Hoskins E, Hood B, Sun M, Krivak T, Conrads T, Edwards R. Detection of the tissue-derived biomarker peroxiredoxin 1 in serum of patients with ovarian cancer: A biomarker feasibility study Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.114 |
0.398 |
|
| 2010 |
Teng PN, Bateman NW, Hood BL, Conrads TP. Advances in proximal fluid proteomics for disease biomarker discovery. Journal of Proteome Research. 9: 6091-100. PMID 21028795 DOI: 10.1021/pr100904q |
0.59 |
|
| 2010 |
Zeng X, Hood BL, Sun M, Conrads TP, Day RS, Weissfeld JL, Siegfried JM, Bigbee WL. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. Journal of Proteome Research. 9: 6440-9. PMID 20931982 DOI: 10.1021/Pr100696N |
0.404 |
|
| 2010 |
Rungruang B, Hood BL, Sun M, Hoskins E, Conrads TP, Zorn KK. Novel surgical approaches for sampling the ovarian surface epithelium and proximal fluid proteome. Journal of Proteome Research. 9: 6071-6. PMID 20873867 DOI: 10.1021/Pr100451F |
0.355 |
|
| 2010 |
Bateman NW, Sun M, Hood BL, Flint MS, Conrads TP. Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase. Journal of Proteome Research. 9: 5311-24. PMID 20681588 DOI: 10.1021/Pr100580E |
0.684 |
|
| 2010 |
Teng PN, Rungruang BJ, Hood BL, Sun M, Flint MS, Bateman NW, Dhir R, Bhargava R, Richard SD, Edwards RP, Conrads TP. Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis. Journal of Proteome Research. 9: 4161-9. PMID 20518575 DOI: 10.1021/Pr100382V |
0.646 |
|
| 2010 |
Conrads TP, Hood BL, Flint MS, Jones-Laughner J, Sun M, Jobe B, Davison J. Abstract 4565: Tissue protein biomarkers of neoplastic progression in Barrett's esophagus Cancer Research. 70: 4565-4565. DOI: 10.1158/1538-7445.Am10-4565 |
0.468 |
|
| 2010 |
Zeng X, Hood BL, Zhao T, Conrads TP, Sun M, Day RS, Gopalakrishnan V, Grover H, Weissfeld JL, Siegfried JM, Bigbee WL. Abstract 4564: Lung cancer serum biomarker discovery using label free LC-MS/MS Cancer Research. 70: 4564-4564. DOI: 10.1158/1538-7445.Am10-4564 |
0.421 |
|
| 2010 |
Beck GR, Camalier CE, Hood B, Conrads TP. Abstract 3789: Elevated inorganic phosphate stimulates immediate early gene expression and requires FGF receptor signaling Cancer Research. 70: 3789-3789. DOI: 10.1158/1538-7445.Am10-3789 |
0.344 |
|
| 2010 |
Flint MS, Hood BL, Bateman NW, Conrads TP. Abstract 2572: Quantitative proteomic and genomic analyses reveal that stress hormones induce a drug resistant phenotype of triple negative breast cancer cells treated with paclitaxel Cancer Research. 70: 2572-2572. DOI: 10.1158/1538-7445.Am10-2572 |
0.446 |
|
| 2009 |
Flint MS, Kim G, Hood BL, Bateman NW, Stewart NA, Conrads TP. Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway. Psychoneuroendocrinology. 34: 1533-41. PMID 19560278 DOI: 10.1016/J.Psyneuen.2009.05.008 |
0.656 |
|
| 2009 |
Hood BL, Stewart NA, Conrads TP. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation. Clinics in Laboratory Medicine. 29: 115-38. PMID 19389555 DOI: 10.1016/J.Cll.2009.01.007 |
0.406 |
|
| 2009 |
Hood BL, Malehorn DE, Conrads TP, Bigbee WL. Serum proteomics using mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 520: 107-28. PMID 19381950 DOI: 10.1007/978-1-60327-811-9_8 |
0.454 |
|
| 2008 |
Cheung W, Darfler MM, Alvarez H, Hood BL, Conrads TP, Habbe N, Krizman DB, Mollenhauer J, Feldmann G, Maitra A. Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. 8: 608-16. PMID 18849643 DOI: 10.1159/000161012 |
0.397 |
|
| 2008 |
Abbatiello SE, Pan YX, Zhou M, Wayne AS, Veenstra TD, Hunger SP, Kilberg MS, Eyler JR, Richards NG, Conrads TP. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. Journal of Proteomics. 71: 61-70. PMID 18541474 DOI: 10.1016/J.Jprot.2007.11.009 |
0.323 |
|
| 2005 |
Conrads TP, Hood BL, Petricoin EF, Liotta LA, Veenstra TD. Cancer proteomics: many technologies, one goal. Expert Review of Proteomics. 2: 693-703. PMID 16209649 DOI: 10.1586/14789450.2.5.693 |
0.309 |
|
| 2005 |
Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, Veenstra TD, Conrads TP, Goldsmith P, Fishman D, Petricoin EF, Liotta LA. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clinical Chemistry. 51: 1933-45. PMID 16099937 DOI: 10.1373/clinchem.2005.052944 |
0.31 |
|
| Show low-probability matches. |